Johnson Matthey PLC (LON:JMAT) Insider Buys £352.35 in Stock

Johnson Matthey PLC (LON:JMATGet Rating) insider Stephen Oxley purchased 15 shares of the stock in a transaction dated Wednesday, May 18th. The shares were purchased at an average price of GBX 2,349 ($28.96) per share, with a total value of £352.35 ($434.36).

Stephen Oxley also recently made the following trade(s):

  • On Wednesday, May 18th, Stephen Oxley bought 15 shares of Johnson Matthey stock. The shares were purchased at an average cost of GBX 2,349 ($28.96) per share, with a total value of £352.35 ($434.36).

LON JMAT opened at GBX 2,277 ($28.07) on Thursday. Johnson Matthey PLC has a 12 month low of GBX 1,650 ($20.34) and a 12 month high of GBX 3,252 ($40.09). The firm has a market capitalization of £4.18 billion and a PE ratio of 29.53. The company’s 50 day simple moving average is GBX 2,001.84 and its 200 day simple moving average is GBX 2,025.19. The company has a debt-to-equity ratio of 54.77, a current ratio of 1.34 and a quick ratio of 0.72.

A number of equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a GBX 2,000 ($24.65) price target on shares of Johnson Matthey in a report on Monday, April 11th. Berenberg Bank cut their target price on Johnson Matthey from GBX 2,800 ($34.52) to GBX 2,550 ($31.43) and set a “buy” rating on the stock in a research note on Friday, January 28th. Barclays reiterated an “equal weight” rating and set a GBX 2,110 ($26.01) price target on shares of Johnson Matthey in a research report on Friday, April 29th. Finally, Morgan Stanley reissued an “equal weight” rating on shares of Johnson Matthey in a report on Wednesday, May 11th. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of GBX 2,300 ($28.35).

About Johnson Matthey (Get Rating)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Articles

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.